Rozrolimupab

Rozrolimupab
Systematic (IUPAC) name
1. Anti-RhD recombinant human polyclonal antibody composed of 25 unique IgG1 antibodies
2. Recombinant human antigen-specific polyclonal antibody (pAb) against RhD antigen expressed in Chinese hamster ovary cells
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 909402-77-3 N
ATC code None
Chemical data
Formula  ?
Mol. mass Antibodies in the 144.8 -148.8 kDa range
 N(what is this?)  (verify)

Rozrolimupab (Sym001) is a polyclonal antibody used in the treatment of autoimmune thrombocytopenic purpura, prevention of isoimmunization in Rh-negative pregnant women.[1]

This drug was developed by Symphogen A/S.

References

  1. ^ STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - ROZROLIMUPAB, American Medical Association.